Skip to main content
OpenTrials

Clinical trial condition

Melanoma

Explore clinical trials studying Melanoma. Study availability and eligibility vary by location and protocol.

2,208 public trials 376 recruiting studies
Refine in advanced search Browse all conditions

Melanoma trial results

Active, Not Recruiting

Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery

NCT01274338

Conditions
Melanoma, Melanoma of Unknown Primary, Neoplasms, +14 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Providence Hospital Mobile, Alabama, United States
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • Alaska Regional Hospital Anchorage, Alaska, United States
View all 938 locations
View Trial Details
Active, Not Recruiting

Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)

NCT02465060

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Lymphoma, +138 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Thomas Hospital Fairhope, Alabama, United States
  • Mobile Infirmary Medical Center Mobile, Alabama, United States
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
View all 1411 locations
View Trial Details
Active, Not Recruiting

Ipilimumab With or Without Sargramostim in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery

NCT01134614

Conditions
Advanced Melanoma, Melanoma, Metastatic Melanoma, +18 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Stanford Cancer Institute Palo Alto Palo Alto, California, United States
  • VA Palo Alto Health Care System Palo Alto, California, United States
  • Eisenhower Medical Center Rancho Mirage, California, United States
View all 257 locations
View Trial Details
Active, Not Recruiting

Testing Two Different Treatment Schedules of Dabrafenib and Trametinib for Skin Cancer Which Has Spread

NCT02196181

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +12 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
View all 753 locations
View Trial Details
Active, Not Recruiting

Tacrolimus, Nivolumab, and Ipilimumab in Treating Kidney Transplant Recipients With Selected Unresectable or Metastatic Cancers

NCT03816332

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Basal Cell, +42 more
Locations
  • Moffitt Cancer Center - McKinley Campus Tampa, Florida, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Northwestern University Chicago, Illinois, United States
  • Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
View Trial Details
Active, Not Recruiting

A Study to Assess IPN01194 When Administered Alone in Adults With Advanced Solid Tumours

NCT06305247

Conditions
Carcinoma, Carcinoma, Squamous Cell, Colonic Diseases, +27 more
Locations
  • The Angeles Clinic and Research Institute - California Los Angeles, California, United States
  • Yale Cancer Center - New Heaven New Haven, Connecticut, United States
  • Sarah Cannon Research Institute (SCRI) - Nashville Nashville, Tennessee, United States
  • Virginia Cancer Specialist Fairfax, Virginia, United States
View Trial Details
Active, Not Recruiting

A Phase I/II Study of DYP688 in Patients With Metastatic Uveal Melanoma and Other GNAQ/11 Mutant Melanomas

NCT05415072

Conditions
Eye Diseases, Eye Neoplasms, Melanoma, +15 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Columbia University Medical Center New York, United States
  • Memorial Sloane Ketterin Cancer Ctr New York, United States
  • Novartis Investigative Site Westmead, New South Wales, Australia
View Trial Details

Related conditions